BCR antibody (AA 50-100)

Catalog No. ABIN1977890

The Rabbit Polyclonal anti-BCR antibody has been validated for IF, FACS, ICC, IP and PLA. It is suitable to detect BCR in samples from Human.

Quick Overview for BCR antibody (AA 50-100) (ABIN1977890)

Target: BCR (Breakpoint Cluster Region (BCR))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This BCR antibody is un-conjugated

Application: Immunofluorescence (IF), Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunoprecipitation (IP), Proximity Ligation Assay (PLA)

Product Details anti-BCR Antibody

Binding Specificity: AA 50-100

Specificity: Region between residue 50 and 100 of human breakpoint cluster region using the numbering given in entry NP_004318.3 (GeneID 613).

Purification: Immunoaffinity purified

Isotype: IgG

Application Details

Application Notes: Approved: Flo, ICC (1:500 - 1:2000), IF (1:500 - 1:2000), IP (10 μg/mg lysate), PLA (1:1000 - 1:20000)

Usage: Immunocytochemistry: Epitope retrieval with citrate buffer  pH 6.0 is recommended for FFPE cells. For cytospin preparations of formaldehyde fixed cells permeabilization with Triton-X 100 is recommended.

Not recommended for: WB

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: Tris-citrate/phosphate buffer,  pH 7-8, 0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 2-8°C for up to 1 year.

Expiry Date: 12 months

Target Details for BCR

Target: BCR (Breakpoint Cluster Region (BCR))

Alternative Name: CML / BCR

Background: Name/Gene ID: BCR
Subfamily: BCR
Family: Protein Kinase

Synonyms: BCR, Acute lymphocytic leukemia, ALL, BCR1, BCR/FGFR1 chimera protein, Breakpoint cluster region, Chronic myeloid leukemia, D22S11, CML, D22S662, Philadelphia chromosome, PHL, FGFR1/BCR chimera protein

Gene ID: 613

Pathways: Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling